Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer
Year: 2017
Type: article
Study design: Observational Study
Source: Diseases of the Esophagus
DOI: 10.1093/dote/dox015
Institution: Oregon Health & Science University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2610697310
